|
|
Article: Spectrum Health Seeks Patients With Metastatic Colorectal Cancer For Study Of New Drug.
- Article from:
- Business Wire
- Article date:
- September 29, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Sept. 29, 2003
Spectrum Health Cancer Center officials today announced that they are enrolling patients for two new clinical research trials for colorectal cancer. They will test a new drug's ability to limit or halt the growth of new blood vessels in tumors and are looking for patients who wish to participate.
The studies are called CONFIRM 1 and CONFIRM 2, an acronym of Colorectal Oral Novel Therapy for the Inhibition of Angiogenesis and Retarding of Metastases. It is hoped the drug will promote anti-angiogenesis.
Tumor angiogenesis is the rapid growth of a ...